Page last updated: 2024-11-03

ritanserin and Hyperphagia

ritanserin has been researched along with Hyperphagia in 1 studies

Ritanserin: A selective and potent serotonin-2 antagonist that is effective in the treatment of a variety of syndromes related to anxiety and depression. The drug also improves the subjective quality of sleep and decreases portal pressure.
ritanserin : A thiazolopyrimidine that is 5H-[1,3]thiazolo[3,2-a]pyrimidin-5-one which is substituted at position 7 by a methyl group and at position 6 by a 2-{4-[bis(4-fluorophenyl)methylidene]piperidin-1-yl}ethyl group. A potent and long-acting seratonin (5-hydroxytryptamine, 5-HT) antagonist of the subtype 5-HT2 (Ki = 0.39 nM), it is used in the treatment of a variety of disorders including anxiety, depression and schizophrenia. It has little sedative action.

Hyperphagia: Ingestion of a greater than optimal quantity of food.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sugimoto, Y1
Yamada, J1
Yoshikawa, T1
Horisaka, K1

Other Studies

1 other study available for ritanserin and Hyperphagia

ArticleYear
The involvement of 5-HT1B receptors in the inhibitory effects of nitric oxide synthase inhibitor on 2-deoxy-D-glucose-induced hyperphagia in rats.
    Neuroreport, 1997, Aug-18, Volume: 8, Issue:12

    Topics: Analysis of Variance; Animals; Deoxyglucose; Enzyme Inhibitors; Hyperphagia; Male; Metergoline; NG-N

1997